SITC Cancer Immunotherapy Guideline News

SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma . " This ...
0 comments
SITC is pleased to announce a new educational offering for the society’s clinical practice guidelines – SITC’s Cancer Immunotherapy Guidelines Mini Modules. Designed for practitioners with a desire to learn but with limited ...
0 comments
SITC’s Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the clinical practice guidelines. On-demand ...
0 comments
The SITC Multiple Myeloma Expert Panel has updated the guidelines content and recommendations based on the November 30, 2021 FDA approval of daratumumab in combination with carfilzomib and dexamethasone (D-Kd) for adult patients ...
0 comments
The new hepatocellular carcinoma immunotherapy treatment algorithm was derived from the expert panel recommendations in the published SITC clinical practice guideline . This algorithm, available only in the free SITC ...
0 comments
On August 27, 2021, the indication for atezolizumab in combination with nab-paclitaxel as treatment for patients with triple-negative breast cancer (TNBC) whose tumors express PD-L1 was voluntarily withdrawn by the manufacturer. ...
0 comments
The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, developed to provide clinicians with an on-the-go and easy-to-navigate reference with interactive ...
0 comments
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma ” was published in JITC September 12, 2021. SITC’s hepatocellular carcinoma ...
0 comments
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer ” was published in JITC August 13, 2021. SITC’s breast cancer expert panel developed this ...
0 comments
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer ” was published in JITC July 15, 2021 as an update to SITC’s 2017 guidelines on bladder ...
0 comments
The “ Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events ” was published in JITC June 25, 2021. While ICIs ...
0 comments